CompaniesIncuron

Incuron

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

3

As Collaborator

3

Total Enrollment

397

By Phase

EARLY_PHASE1: 1PHASE1/PHASE2: 1PHASE1: 3

By Status

RECRUITING: 2COMPLETED: 2TERMINATED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT01905228
NCT02931110
NCT03727789
NCT04870944
NCT05498792
Hover over trial bars to see details

Recent Trials

NCT05498792Collaborator
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
EARLY_PHASE1Recruiting
12 participants
Started: Nov 30, 2022 · Completed: Sep 2, 2026
NCT05383053Lead Sponsor
Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment Patients
N/ACompleted
227 participants
Started: Jul 22, 2022 · Completed: Sep 8, 2022
NCT04870944Collaborator
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
PHASE1/PHASE2Recruiting
63 participants
Started: Jan 28, 2022 · Completed: Dec 31, 2026
NCT03727789Collaborator
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
PHASE1Terminated
7 participants
Started: Jul 1, 2019 · Completed: Jan 16, 2024
NCT02931110Lead Sponsor
Study of IV CBL0137 in Previously Treated Hematological Subjects
PHASE1Terminated
5 participants
Started: Jan 31, 2017 · Completed: Oct 31, 2020
View all 6 trials →